A detailed history of Ameriprise Financial Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 241,208 shares of CDNA stock, worth $5.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
241,208
Previous 190,953 26.32%
Holding current value
$5.62 Million
Previous $2.97 Million 153.96%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $724,174 - $1.71 Million
50,255 Added 26.32%
241,208 $7.53 Million
Q2 2024

Aug 14, 2024

BUY
$7.56 - $16.15 $22,339 - $47,723
2,955 Added 1.57%
190,953 $2.97 Million
Q1 2024

May 15, 2024

SELL
$7.96 - $12.37 $13,356 - $20,756
-1,678 Reduced 0.88%
187,998 $1.99 Million
Q4 2023

Feb 14, 2024

SELL
$4.9 - $12.86 $448,301 - $1.18 Million
-91,490 Reduced 32.54%
189,676 $2.28 Million
Q3 2023

Nov 14, 2023

BUY
$7.0 - $11.26 $343,609 - $552,719
49,087 Added 21.15%
281,166 $1.97 Million
Q2 2023

Aug 14, 2023

BUY
$7.61 - $9.46 $1.02 Million - $1.26 Million
133,568 Added 135.59%
232,079 $1.97 Million
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $137,509 - $274,240
15,573 Added 18.78%
98,511 $900,000
Q4 2022

Feb 14, 2023

SELL
$10.88 - $20.05 $452,183 - $833,298
-41,561 Reduced 33.38%
82,938 $946,000
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $85,583 - $140,632
-5,329 Reduced 4.1%
124,499 $2.12 Million
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $426,683 - $827,129
20,824 Added 19.1%
129,828 $2.79 Million
Q1 2022

May 16, 2022

SELL
$28.19 - $46.6 $379,465 - $627,282
-13,461 Reduced 10.99%
109,004 $4.03 Million
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $709,670 - $1.27 Million
17,225 Added 16.37%
122,465 $5.57 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $2.29 Million - $3.56 Million
38,748 Added 58.27%
105,240 $6.67 Million
Q2 2021

Aug 16, 2021

BUY
$63.02 - $95.11 $690,069 - $1.04 Million
10,950 Added 19.71%
66,492 $6.09 Million
Q1 2021

May 17, 2021

SELL
$57.62 - $95.6 $1.73 Million - $2.86 Million
-29,953 Reduced 35.03%
55,542 $3.78 Million
Q4 2020

Feb 12, 2021

BUY
$41.43 - $77.09 $2.36 Million - $4.4 Million
57,036 Added 200.41%
85,495 $6.18 Million
Q3 2020

Nov 16, 2020

SELL
$30.88 - $37.94 $3,983 - $4,894
-129 Reduced 0.45%
28,459 $1.08 Million
Q2 2020

Aug 14, 2020

BUY
$18.95 - $35.43 $2,671 - $4,995
141 Added 0.5%
28,588 $1.01 Million
Q1 2020

May 15, 2020

SELL
$13.94 - $28.25 $585,940 - $1.19 Million
-42,033 Reduced 59.64%
28,447 $621,000
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $1.43 Million - $2.11 Million
-74,289 Reduced 51.32%
70,480 $1.52 Million
Q3 2019

Nov 14, 2019

SELL
$20.03 - $40.08 $5.79 Million - $11.6 Million
-289,304 Reduced 66.65%
144,769 $3.27 Million
Q2 2019

Aug 14, 2019

BUY
$25.78 - $39.77 $1.89 Million - $2.92 Million
73,381 Added 20.34%
434,073 $15.6 Million
Q1 2019

May 15, 2019

BUY
$22.09 - $39.21 $3.31 Million - $5.87 Million
149,713 Added 70.96%
360,692 $11.4 Million
Q4 2018

Feb 14, 2019

BUY
$19.89 - $30.02 $248,525 - $375,099
12,495 Added 6.3%
210,979 $5.3 Million
Q3 2018

Nov 14, 2018

BUY
$12.1 - $28.85 $2.4 Million - $5.73 Million
198,484 New
198,484 $5.73 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.25B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.